The steroid medication linked to the current fungal meningitis outbreak was produced and widely distributed by the New England Compounding Center in Framingham , Massachusetts , one of many compounding pharmacies across the country that has crossed the line between traditional compounding and large scale drug production . The injectable steroid medication produced at the center was never approved by the FDA and was not manufactured in accordance with the FDA ' s rigorous manufacturing standards designed to ensure that drugs are sterile and uncontaminated with such germs as bacteria or fungi before being sold and distributed .
